Align Ventures Closes Oversubscribed $125M Early-Stage Fund II
Align Ventures has closed an oversubscribed $125M Early-Stage Fund II, exceeding its $100M target. The firm said the close brought total platform assets under management to more than $2.5B as of June 2026.
The vehicle will make $2M-$10M initial investments in 15-20 consumer brands across beauty, personal care, health, wellness, pet, and home. That structure gives Align enough capital to write meaningful early checks while maintaining a concentrated portfolio.
The fund matters because consumer investing punishes vague conviction. Brands need more than attention. They need repeat purchases, retail execution, healthy economics, and the operational discipline to turn a product into a habit. Align is using Fund II to argue that a concentrated portfolio, active support, and follow-on capital create stronger alignment than a broad collection of passive investments.
What Happened
Align announced the final close on July 28, 2026. The firm said returning Fund I investors participated alongside new limited partners, although it did not identify those investors or disclose the fund's economics.
The regulatory timeline shows how the vehicle developed before the final close. An SEC Form D/A for Align Ventures II, L.P. reported a March 10, 2025, first sale and $84.17M sold as of June 5, 2026. The later $125M announcement reflects the completed raise, while Align's more than $2.5B assets under management describe the broader platform and remain a company-reported metric.
Fund II is designed to make $2M-$10M initial investments across 15-20 brands. Align plans to focus on beauty, personal care, health, wellness, pet, and home, categories where a brand can become culturally visible long before its economics prove durable.
Why This Fund Matters
A $125M fund targeting only 15-20 companies creates a different operating mandate from a high-volume seed portfolio. Align has room to make meaningful initial investments, but the portfolio construction requires the team to choose carefully and spend time where it has developed genuine conviction.
That concentration is only part of the strategy. Align says it often provides the first venture check, then supports portfolio companies with follow-on capital, secondary liquidity, board involvement, and access to operators and advisers. Fund II expands the firm's early-stage investment capacity without separating it from the broader support platform.
For founders, that structure can matter as much as the headline fund size. Consumer brands routinely face decisions around retail expansion, inventory, pricing, customer acquisition, product extensions, and leadership before the market agrees on what the business is worth. Capital helps, but judgment during those transition points is what keeps growth from becoming expensive theater.
The Track Record Behind Fund II
Align says its 2019-vintage Fund I ranks in the top decile for TVPI, net IRR, and DPI among comparable U.S. venture funds, citing Carta. Because the underlying benchmark is proprietary, the ranking should be understood as an Align-reported performance claim rather than an independently verified comparison.
The firm points to exits involving Coterie, Touchland, Hims, and Billie as evidence supporting the new raise. Those outcomes span baby care, personal care, digital health, and grooming, but the common thread is not a single product category. It is the ability to identify consumer behavior capable of supporting repeat demand, broader distribution, or a strategic exit.
Fund II already offers an early example of the firm's approach. Align said it warehoused an early-stage investment in California Naturals for the vehicle and recently participated in the company's Series B. The sequence illustrates how the firm intends to operate: establish conviction early, retain the flexibility to add capital, and avoid treating every portfolio company as an equal-weight investment.
The Consumer Strategy
Consumer venture investing can appear deceptively accessible because the products are familiar. The difficult part is separating temporary attention from durable behavior, especially when retail distribution, gross margin, inventory management, and repeat purchases all influence the outcome simultaneously.
Align's focus on beauty, personal care, health, wellness, pet, and home places Fund II in categories shaped by routine purchasing behavior. These are products consumers may use daily or weekly, creating strong loyalty when they perform well and equally significant consequences when brand momentum outpaces operational quality.
The firm's broader strategy also extends selectively into technologies that influence how consumers live, connect, and shop. Align's official portfolio and team materials describe a platform supporting both consumer brands and selected technology companies across stages, but Fund II's announced mandate remains deliberately focused on early-stage consumer businesses.
The Team Managing the Vehicle
Ben Bryce, founder and managing partner, and Grant Hosking, managing partner, lead the vehicle. The official team page says Ben Bryce brings more than 15 years of experience in consumer investing, capital raising, and portfolio management, while Grant Hosking contributes more than 15 years across venture capital, investment banking, operating roles, and private equity.
The investment team identified in the fund announcement also includes Andrew Ferrero, Peyton Raun, and Melanie Singh. Align describes the group as bringing experience across consumer investing, brand strategy, and operating roles, with backgrounds that include Left Lane Capital and Estée Lauder's New Incubation Ventures.
The firm is also an SEC-registered investment adviser. That status does not validate performance claims or guarantee investment outcomes, but it provides a regulatory reference point for the management platform behind the fund.
What This Signals
The important signal in this fund close is not simply that another venture firm raised capital. It is that limited partners backed a concentrated consumer strategy above its original target while Align continued to position operational involvement as part of its investment model.
Fund II gives Align greater capacity to support early-stage brands without sacrificing selectivity. The disclosed check sizes and portfolio construction create room for meaningful ownership and follow-on support, although the firm has not disclosed its reserve strategy, ownership targets, or detailed fund economics.
The next evidence will come from deployment rather than announcements. The pace of new investments, category mix, follow-on decisions, and ability to translate early consumer attention into durable businesses will determine whether the Fund I playbook scales successfully into a larger second vehicle.
Frequently Asked Questions
How will Align Ventures invest Early-Stage Fund II?
Align plans to make $2M–$10M initial checks across 15–20 consumer brands in beauty, personal care, health, wellness, pet, and home. The disclosed portfolio size indicates a concentrated approach rather than a high-volume seed strategy.
Why is Align Ventures Fund II described as oversubscribed?
Align closed $125M after setting a $100M target, so commitments exceeded the original target by $25M. The firm said both returning Fund I investors and new partners participated, but it did not name the limited partners.
What does Align Ventures' reported $2.5B in AUM include?
Align reported more than $2.5B in total platform AUM as of June 2026. The reviewed public sources do not provide a vehicle-by-vehicle breakdown, so the figure should not be treated as the size of Fund II.
What track record is Align using to support the new fund?
Align points to exits from Coterie, Touchland, Hims, and Billie. The firm also says Fund I ranks in the top decile for TVPI, net IRR, and DPI among 2019-vintage U.S. venture funds, citing Carta; that ranking remains a company-reported claim.
Where the Money Moved
The intelligence briefing of the innovation economy — funding, M&A, debt and fund closes, read as market signal rather than deal announcements.
Subscribe on wherethemoneymoved.com








